H
Hans Peter Dimai
Researcher at Medical University of Graz
Publications - 67
Citations - 1328
Hans Peter Dimai is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Osteoporosis & Bone remodeling. The author has an hindex of 16, co-authored 67 publications receiving 1120 citations. Previous affiliations of Hans Peter Dimai include Danube University Krems & University of Graz.
Papers
More filters
Journal ArticleDOI
Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
Steven Boonen,Jean-Yves Reginster,Jean-Marc Kaufman,Kurt Lippuner,Jose R. Zanchetta,Bente L. Langdahl,René Rizzoli,Stanley Lipschitz,Hans Peter Dimai,Richard Witvrouw,Erik Fink Eriksen,Kim Brixen,Luis Russo,Frank Claessens,Philemon Papanastasiou,Oscar Antunez,Guoqin Su,Christina Bucci-Rechtweg,Josef Hruska,Elodie Incera,Dirk Vanderschueren,Eric S. Orwoll +21 more
TL;DR: Zoledronic acid treatment was associated with a significantly reduced risk of vertebral fracture among men with osteoporosis and results were similar in men with low serum levels of total testosterone.
Journal ArticleDOI
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein,Steven Amrein,Camilla Drexler,Hans Peter Dimai,Harald Dobnig,Klaus Pfeifer,Andreas Tomaschitz,Thomas R. Pieber,Astrid Fahrleitner-Pammer +8 more
TL;DR: In healthy adults, sclerostin serum levels correlate positively with age, BMI, and BMC and negatively with osteocalcin and calcium, and further studies are needed to confirm the findings and to better understand their clinical implications.
Journal ArticleDOI
Daily Oral Magnesium Supplementation Suppresses Bone Turnover in Young Adult Males
Hans Peter Dimai,S. Porta,Gerhard Wirnsberger,M. Lindschinger,I. Pamperl,Harald Dobnig,M. Wilders-Truschnig,Kin-Hing William Lau +7 more
TL;DR: Oral Mg supplementation in normal young adults caused reductions in serum levels of iPTH, ionized Mg2+, and biochemical markers of bone turnover, demonstrating for the first time that oral Mg supplements may suppress bone turnover in young adults.
Journal ArticleDOI
Osteoprotegerin serum levels in women: Correlation with age, bone mass, bone turnover and fracture status
Astrid Fahrleitner-Pammer,Harald Dobnig,Claudia Piswanger-Soelkner,Christine M Bonelli,Hans Peter Dimai,Georg Leb,Barbara Obermayer-Pietsch +6 more
TL;DR: Pre-clinical data have shown that osteoprotegerin (OPG) inhibits osteoclast function and therefore plays an important role in bone remodelling.
Journal ArticleDOI
Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
Astrid Fahrleitner-Pammer,Jutta Claudia Piswanger-Soelkner,Thomas R. Pieber,Barbara Obermayer-Pietsch,Stefan Pilz,Hans Peter Dimai,Guenther Prenner,Karlheinz Tscheliessnigg,Ellen Margrethe Hauge,Rupert Horst Portugaller,Harald Dobnig +10 more
TL;DR: Intravenous IBN reduced fractures, preserved bone mass, and prevented uncoupling of bone formation and resorption after CTP, and the favorable effects on bone turnover were also supported by histomorphometric findings.